<DOC>
	<DOCNO>NCT02236793</DOCNO>
	<brief_summary>The present clinical trial design assess effectiveness BioChaperone PDGF-BB apply 4 µg/cm² every day 20 week associate Standard Care compare Standard Care alone treatment neuropathic neurovascular diabetic foot ulcer . ( In order ensure double-blinding treatment , sterile normal saline solution present multi-dose spray vial BioChaperone PDGF-BB apply patient control group ) .</brief_summary>
	<brief_title>A Phase 3 Clinical Trial Assess Effectiveness BioChaperone PDGF-BB In Treatment Chronic Diabetic Foot Ulcer</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Diabetic Foot</mesh_term>
	<mesh_term>Foot Ulcer</mesh_term>
	<mesh_term>Platelet-derived growth factor BB</mesh_term>
	<criteria>Men woman age 18 year old old , type 1 2 diabetes mellitus Patient single ulcer treat foot Patient able willing provide inform consent Patient able willing comply protocol visit procedure Patient willing use offload method whole duration study Fullthickness plantar , lateral dorsal ulcer extremity ( malleolus ) , exclude interdigits ulcer ( web space ) , extend epidermis dermis , involve bone , tendon , ligament muscle ( grade IA define University Texas Diabetic Wound Classification Grade 1 accord Wagner classification ) Chronic ulcer least six week despite appropriate wound care Ulcer area measure formula Length x Width x 0.8 follow sharp debridement , 1 10 cm² , inclusive Well control infection cellulitis ( systemic antibiotherapy ) Baseline Visit Peripheral neuropathy assess Semmes Weinstein monofilament test bio esthesimeter ( vibration perception threshold ) . Ankle brachial pressure index &gt; 0.60 &lt; 1.3 Women surgically sterile , postmenopausal , agree practice adequate contraception negative pregnancy test screening . Nonnursing Inter digit ulcer Ulcer cause origin : electrical , chemical radiation insult , bedsore , vascular ulcer Charcot deformities ulcer Charcot foot . Wound originate amputation bed Active ulcer infection assess clinical examination radiography necessary . Presence necrosis , purulence sinus tracts remove debridement control standard wound care . Active osteomyelitis affect area target ulcer Poorly control diabetes ( uncontrolled glycemia : HbA1c % &gt; = 10 % ) , renal failure ( serum creatinine &gt; 3.0 mg/dL ) , poor nutritional status ( albumin &lt; 3.0 g/dL total protein &lt; 6.5 g/dL ) Known connective tissue malignant disease Concomitant treatment corticosteroid , immunosuppressive agent , radiation therapy , anticancer chemotherapy Use investigational drug/device growth factor within 30 day Topical application advance wound care wound ( antiseptic , antibiotic , debriders , enzyme ) within 7 day Vascular reconstruction within 8 week Patients expect noncompliant protocol ( available duration trial , treatment wound care compliance ) , felt unsuitable Investigator reason . A history severe cerebrovascular event</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>